Dr. Niamh O’Boyle provides an overview of the SARS-CoV-2 virus and discusses the drugs that are currently in use to treat COVID-19.
COVID-19 is a global pandemic caused by the SARS-CoV-2 virus. There is a huge worldwide effort underway to discover vaccines and new drugs, and to repurpose old drugs to treat this disease.
In this Bruker webinar, Dr. Niamh O’Boyle will discuss the drugs that are currently being used to treat COVID-19: remdesivir, chloroquine and the combination of lopinavir/ritonavir. These drugs are being investigated as part of the World Health Organization’s ‘Solidarity’ international clinical trial. Remdesivir is an anti-viral drug with no other clinical use at present; lopinavir/ritonavir are used for treating HIV. Chloroquine and its related analogue hydroxychloroquine are anti-malarials discovered during one of the major global emergencies of the 20th century – World War II. After a brief introduction to the SARS-CoV-2 virus and the viral life cycle, Dr. O’Boyle will conclude with the structures and mechanisms of action of these drugs.
Pharmacy Trinity College Dublin
Additional Content From Bruker BioSpin
Join Dr. Alexander Stößel for an exploration into the complex workings and evolution of the ear using nano- and micro- CT; from Neadertals to modern mammals.
Stimulating and Recording Neuronal Activity During Traditional fMRI, and the Benefits When Doing This at “Zero” Echo Time
Experts discuss electrical and optical-based techniques capable of stimulating and recording neuronal activity during fMRI, share examples using these tools to study neurovascular coupling, and introduce a method to acquire fMRI data at zero echo time and discuss the advantages over traditional fMRI technique.
Dr. Raanan Carmieli discusses the use of electron paramagnetic resonance (EPR) as a powerful technique for the study of transition metals, organic radical ions and transient radical-pairs in photoexcited systems.
A Comprehensive How-To Demonstration of Higher Throughput Excitation-Contraction Coupling Investigations
Join Michiel Helmes and Diederik Kuster as they demonstrate best practices and new techniques in high-content, higher throughput investigations of excitation-contraction coupling in isolated cardiomyocytes.
OBESITY SERIES 2020: Dr. Ania Jastreboff discusses the current use of anti-obesity pharmacotherapy, mechanisms involved, and agents in various stages of development with considerations for next steps.
Dr. Sharman explains the impact of using NMR for the quality control and release of drug molecules currently in shortage due to the Coronavirus pandemic.